BioAesthetics
Durham
About BioAesthetics
BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics’ initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to plastic and reconstructive surgeons as an off-the-shelf ready, acellular, NAC graft. During the breast reconstruction phase, after a mastectomy, the surgeon would engraft the NAC graft in position onto the patient’s reconstructed breast. The patient’s body would then use this NAC graft as a building frame to regenerate their own NAC. This patent-pending product is currently in the pre-clinical phase.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.7M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Sep 2023)
- Website: bio-aesthetics.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/bioaesthetics-66086 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.